No front page content has been created yet.
Regenix Drugs Ltd incorporated as public ltd company (unlisted) in the year 2007. The Corporate office is located at Chennai. India
Promoters
The promoters are Dr A Ramamurthy and 2500 medical doctors. Dr A Ramamurthy is a post graduate in internal medicine, with gold medal from Madras University. The promoter has 25 years of health care experience as consultant and Director of BG hospital. Founder and Managing director of Grandix pharmaceutical company and Grandix Laboratories, which were sold to Strides Arco Labs in 2007 for 30 Million USD.
Vision
To become a global pharmaceutical company
Mission
To invent or innovate newer medicines and change the outcome of health care positively. Also makes significant changes in the benefits of all stakeholders
Quality policy
We manufacture medicinal product with high degree of responsibility to provide 100 % quality product keeping in mind of safety and efficacy of our product to alleviate the sufferings of patients without fail
Business model
2018-19:
RDL – pharma division launched 12 new products in the field of Gynecology, Pediatrics and diabetology
The manufacturing facility at Alathur for small molecule is recertified for WHO GMP
The plant developed 26 products with Asian CTD dossier
Regenix super specialty lab chain [ NABL accredited] – developing HPV diagnostic kit
The RDL group work force is 850
RDL subsidy Regenix Bioscience raised 50,000,000 INR to set up the Biosimilar facility
The Biosimilar fill finish facility is completed and waiting for Regulatory approval
Recombinant Human Insulin is waiting for Regulatory approval
RDL now exporting pharmaceutical finished goods to South America and Philippines
MOUs for Business collaborations